Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Inflation Reduction Act
Pharma
CMS picks 2nd batch of drugs for IRA price talks
Novo’s booming semaglutide franchise for diabetes and obesity is the standout inclusion in this year's list.
Angus Liu
Jan 17, 2025 9:28am
US drug pricing poised to continue trending upward: Cowen report
Jan 9, 2025 8:29am
How will Trump approach healthcare? Lilly CEO gives some hints
Dec 11, 2024 10:56am
Novo Nordisk to slash prices of Fiasp, Tresiba in 2026
Dec 6, 2024 11:44am
Healthcare could see shake-up on various fronts under Trump: S&P
Dec 3, 2024 2:42pm
As Harris and Trump face off, what's at stake for pharma?
Nov 4, 2024 3:08pm
